Dynavax Technologies | Despesa De Juros Sobre A Dívida



Interest Expense On Debt Alterar Data
AbbVie USD 610M 19M 2024-12
Adma Biologics USD 2.88M 620K 2024-12
Amgen USD 723M 24M 2025-03
AstraZeneca 429M 28M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Dynavax Technologies USD 1.7M 5K 2024-12
Gilead Sciences USD 260M 12M 2025-03
Glaxosmithkline 178.05M 24.73M 2024-12
Merck USD 313M 15M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
TG Therapeutics USD 10.83M 6.86M 2024-09
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Dynavax Technologies Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.